Jonelle K. Lee, MS, BS
Abstract 3338. Concurrent treatment with Pim kinase inhibitor enhances the efficacy of FLT3 inhibitors in AML with FLT3-ITD through...
Gov. Type: Minority Scholar
Abstract 3338. Concurrent treatment with Pim kinase inhibitor enhances the efficacy of FLT3 inhibitors in AML with FLT3-ITD through...
Abstract 990. Functional genomic screen of kinases in high-grade serous ovarian cancer metastasis. What are your long-term goals? I’m...
Abstract 394. Elevated aryl hydrocarbon receptor and leptin receptor expression correlate with prostate cancer progression and may be associated...
Abstract 698. Establishing and characterizing patient derived models from racial/ethnic minority gastric cancer patients to advance cancer precision health...
Abstract 829. p53 dimers elicit tumor-suppressive activities through an altered metabolic program. What are your long-term career objectives? My...
Abstract 670. Distinct biochemical properties of KRAS Q61H mutant render cancer cells resistant to SHP2 inhibitors. What are your...
Abstract 1123. c-Met downregulation contributes to Metformin-induced inhibition of MDA-MB-468 triple-negative breast cancer cells. What are your long-term goals? ...
Abstract 1388. Mutations in transcriptional activators of MHC I antigen presentation, NLRC5 and CIITA, are mutually exclusive and have...
Abstract 399. The glucocorticoid receptor and β-catenin interact in prostate cancer cells and their co-inhibition attenuates stemness and docetaxel...
Abstract 2301. Targeting the MUVB complex or downstream G2/M proteins potentiates CDK4/6 inhibitor efficacy in breast cancer. What are...